Carboplatin sustained delivery system using injectable microspheres

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 52, Issue 8, 2005, Pages 416-422

  Manunta, M L ^a   Gavini, E ^a   Chessa, G ^a,b   Passino, E S ^a   Careddu, G M ^a   Giua, S ^a   Mollica, A ^a   Demontis, M P ^a   Leoni, A ^a   Muzzetto, P ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA SARDEGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; MICROSPHERE;

ANIMAL; ARTICLE; BIODEGRADABLE IMPLANT; DELAYED RELEASE FORMULATION; MALE; RANDOMIZATION; RAT; WISTAR RAT;

ABSORBABLE IMPLANTS; ANIMALS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; DELAYED-ACTION PREPARATIONS; MALE; MICROSPHERES; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 27844610193     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.2005.00751.x     Document Type: Article

References (40)

1. Anderson, J. M., and S. S. Matthew, 1997: Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Dev. Rev. 28, 2-24.
2. Bergman, P. J., G. MacEwen, I. D. Kurzman, C. J. Henry, A. S. Hammer, D. W. Knapp, A. Hale, S. A. Kruth, M. K. Klein, J. Klausner, A. M. Norris, D. McCaw, R. C. Straw, and S. J. Withrow, 1996: Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). J. Vet. Intern. Med. 222, 76-81.
3. Boisdron-Celle, M., P. Menei, and J. P. Benoit, 1995: Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. J. Pharm. Pharmacol. 47, 108-114.
4. Boisdron-Celle, M., A. Lebouil, P. Allain, and E. Gamelin, 2001: Pharmacokinetic properties of platinium derivatives. Bull. Cancer 88, S14-S19.
5. Brem, H., and P. Gabikian, 2001: Biodegradable polymer implants to treat brain tumors. J. Control. Release 74, 63-67.
6. Brem, H., and H. C. Lawson, 1999: The development of new brain tumor therapy utilizing the local and sustained delivery of chemotherapeutic agents from biodegradable polymers. Cancer 86, 197-199.
7. Calvert, A. H., D. R. Newell, L. A. Gumbrell, S. O'Reilly, M. Burnell, F. E. Boxall, Z. H. Siddik, I. R. Judson, M. E. Gore, and E. Wiltshaw, 1989: Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J. Clin. Oncol. 7, 1748-1756.
8. Chen, W., and D. R. Lu, 1999: Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization. J. Microencapsul. 16, 551-563.
9. Collins, J. M., 1984: Pharmacologic rationale for regional drug delivery. J. Clin. Oncol. 2, 498-504.
10. Dernell, W. S., S. J. Withrow, B. E. Powers, M. Lafferty, K. M. Holland, J. Scott, R. Scott, and R. L. Dunn, 1998a: Toxicity and pharmacokinteic of cisplatin released from polymer delivery devices injected subcutaneously in dogs. Vet. Cancer Soc. 18th Ann. Conf. Proc. Esbes Park, CO, USA, p.5.
11. Dernell, W. S., R. C. Straw, S. J. Withrow, B. E. Powers, S. M. Fujita, G. S. Yewey, K. F. Joseph, R. L. Dunn, S. L. Whitman, and G. L. Southard, 1998b: Apparent interaction of dimethyl sulfoxide with cisplatin released from polymer deliver devices injected subcutaneously in dogs. J. Drug. Target 5, 391-396.
12. Ehrhart, N., W. E. Dernell, E. J. Ehhart, J. M. Hutchison, E. B. Douple, J. H. Brekke, R. C. Straw, and S. J. Withrow, 1999: Effects of a controlled-release cisplatin delivery system used after resection of mammary carcinoma in rat. Am. J. Vet. Res. 60, 1347-1351.
13. Emerich, D. F., S. R. Winn, Y. Hu, J. Marsh, P. Snodgrass, D. LaFreniere, T. Wiens, B. P. Hasler, and R. T. Bartus, 2000a: Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumours. Pharm. Res. 17, 767-775.
14. Emerich, D. F., S. R. Winn, P. Snodgrass, D. LaFreniere, M. Agostino, T. Wiens, H. Xiong, and R. T. Bartus, 2000b: Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumours. Pharm. Res. 17, 776-781.
15. Emerich, D. F., P. Snodgrass, D. LaFreniere, R. L. Dean, H. Salzberg, J. Marsh, B. Perdomo, M. Arastu, S. R. Winn, and R. T. Bartus, 2002a: Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions. Pharm. Res. 19, 1052-1060.
16. Emerich, D. F., S. R. Winn, and R. T. Bartus, 2002b: Injection of chemotherapeutic microspheres and glioma. III: parameters to optimize efficacy. Cell. Transplant. 11, 35-45.
17. Emerich, D. F., S. R. Winn, and R. T. Bartus, 2002c: Injection of chemotherapeutic microspheres and glioma. IV: eradicating tumours in rats. Cell. Transplant. 11, 47-54.
18. Gavini, E., V. Sanna, C. Juliano, and P. Giunchedi, 2003: Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of Ketoprofen. J. Microencapsul. 20, 193-201.
19. Gavini, E., P. Chetoni, M. Cossu, M. G. Alvarez, M. F. Saettone, and P. Giunchedi, 2004: PLGA microspheres for the ocular delivery of a peptide drug: vancomycin. Emulsification/spray-drying as preparation method; in vitro/in vivo studies. Eur. J. Pharm. Biopharm. 57, 207-212.
20. Gavini, E., M. L. Manunta, S. Giua, G. Achenza, and P. Giunchedi, 2005: Spray-dried PDLLA microspheres containing carboplatin for veterinary use: in vitro and in vivo studies. AAPS Pharm. Sci. Tech., in press.
21. Giunchedi, P., and U. Conte, 1995: Spray-drying as a preparation method of microparticulate drug delivery systems. An overview. S.T.P. Pharma Sci. 5, 276-290.
22. Giunchedi, P., E. Gavini, G. Bonacucina, and G. F. Calmieri, 2000: Tabletted polylactide microspheres prepared by a w/o emulsion-spray drying method. J. Microencapsul. 17, 711-720.
23. Hahn, K. A., M. F. McEntee, G. E. Daniel, A. M. Legendre, and M. L. Nolan, 1997: Hematologic and systemic toxicoses associated with carboplatin administration in cats. Am. J. Vet. Res. 58, 667-679.
24. Hecquet, B., C. Fournier, G. Depadt, and P. Cappelaere, 1984: Preparation and release kinetics of microencapsulated cisplatin with ethicellulose. J. Pharm. Pharmacol. 36, 803-807.
25. Ike, O., Y. Shimizu, R. Wada, S. H. Hyon, and Y. Ikada, 1992: Controlled cisplatin delivery system using poly (D, L-Lactic acid). Biomaterials 13, 230-234.
26. Lana, S. E., W. E. Dernell, S. M. LaRue, M. J. Lafferty, E. B. Douple, J. H. Brekke, and S. J. Withrow, 1997: Slow release cisplatin combined with radiation for the treatment of canine nasal tumours. Vet. Radiol. Ultrasound 38, 474-478.
27. Lee, F. H., R. Canetta, B. F. Issell, and L. Lenaz, 1983: New platinum complexes in clinical trials. Cancer Treat. Rev. 10, 39-51.
28. Lesniak, M. S., R. Langer, and H. Brem, 2001: Drug delivery to tumors of the central nervous system. Curr. Neurol. Neurosci. Rep. 1, 210-216.
29. Los, G., E. M. Verdegaal, P. H. Mutsaers, and J. G. McVie, 1991: Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemother. Pharmacol. 28, 159-165.
30. Markman, M., S. Cleary, and S. B. Howell, 1985a: Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protection. Eur. J. Cancer Clin. Oncol. 21, 1015-1018.
31. Markman, M., S. Cleary, C. E. Pleifle, and S. B. Howell, 1985b: High-dose intracavitary cisplatin with intravenous thiosulphate. Low incidence of serious neurotoxicity. Cancer 56, 2364-2366.
32. Menei, P., and J. P. Benoit, 2003: Implantable drug-releasing biodegradable microspheres for local treatment of brain glioma. Acta Neurochir. Suppl. 88, 51-55.
33. Menei, P., M. C. Venier, E. Gamelin, J. P. Saint-Andre, G. Hayek, E. Jadaud, D. Fournier, P. Mercier, G. Guy, and J. P. Benoit, 1999: Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study. Cancer 86, 325-330.
34. Olivi, A., and H. Brem, 1994: Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas. Recent Results Cancer Res. 135, 149-54.
35. Özalp, Y., N. Özdemir, S. Kocagöz, and V. Hasirci. 2001: Controlled release of Vancomycin from biodegradable microcapsules. J. Microencapsul. 18, 89-110.
36. Page, R. L., M. McEntee, S. L. George, P. L. Williams, G. L. Heidner, C. A. Novtney, J. E. Riviere, M. W. Dewhirst, and D. E. Thrall, 1993: Pharmacokinetic and phase 1 evaluation of carboplatin in dogs. J. Vet. Intern. Med. 7, 235-240.
37. Perrin, D., and J. English, 1997: Polyglycolide and polyactide. In: Domb, A., J., Kost, and D., Wiseman (eds), Handbook of Biodegradable Polymers. pp. 3-27. Harwood Academic Publishers, Amsterdam.
38. Straw, R. C., S. J. Withrow, E. B. Douple, J. H. Brekke, M. F. Cooper, P. D. Schwarz, D. S. Greco, and B. E. Powers, 1994: Effects of Cis-diamminedichloroplatinum II released from D,L-polylactic acid implanted adjacent to cortical allografts in dogs. J. Orthop. Res. 12, 871-877.
39. Wada, R., Y. Tabata, S. H. Hyon, and Y. Ikada, 1988: Preparation of poly(lactic acid) microspheres containing anticancer drugs. Bull. Inst. Chem. Res. Kyoto Univ. 66, 241-250.
40. Williams, J. A., X. Yuan, L. E. Dillehay, V. R. Shastri, H. Brem, and J. R. Williams, 1998: Synthetic, implantable polymers for local delivery of IUdR to experimental human malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 42, 631-639.